1. Home
  2. AXSM vs OPCH Comparison

AXSM vs OPCH Comparison

Compare AXSM & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • OPCH
  • Stock Information
  • Founded
  • AXSM 2012
  • OPCH N/A
  • Country
  • AXSM United States
  • OPCH United States
  • Employees
  • AXSM N/A
  • OPCH N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • OPCH Medical/Nursing Services
  • Sector
  • AXSM Health Care
  • OPCH Health Care
  • Exchange
  • AXSM Nasdaq
  • OPCH Nasdaq
  • Market Cap
  • AXSM 5.1B
  • OPCH 5.3B
  • IPO Year
  • AXSM 2015
  • OPCH N/A
  • Fundamental
  • Price
  • AXSM $110.12
  • OPCH $30.74
  • Analyst Decision
  • AXSM Strong Buy
  • OPCH Strong Buy
  • Analyst Count
  • AXSM 17
  • OPCH 7
  • Target Price
  • AXSM $171.65
  • OPCH $35.86
  • AVG Volume (30 Days)
  • AXSM 672.7K
  • OPCH 1.5M
  • Earning Date
  • AXSM 08-04-2025
  • OPCH 07-30-2025
  • Dividend Yield
  • AXSM N/A
  • OPCH N/A
  • EPS Growth
  • AXSM N/A
  • OPCH N/A
  • EPS
  • AXSM N/A
  • OPCH 1.25
  • Revenue
  • AXSM $432,157,000.00
  • OPCH $5,185,122,000.00
  • Revenue This Year
  • AXSM $62.57
  • OPCH $13.22
  • Revenue Next Year
  • AXSM $59.96
  • OPCH $8.52
  • P/E Ratio
  • AXSM N/A
  • OPCH $24.58
  • Revenue Growth
  • AXSM 72.16
  • OPCH 16.98
  • 52 Week Low
  • AXSM $72.21
  • OPCH $21.39
  • 52 Week High
  • AXSM $139.13
  • OPCH $35.53
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 56.52
  • OPCH 43.83
  • Support Level
  • AXSM $108.48
  • OPCH $29.79
  • Resistance Level
  • AXSM $114.66
  • OPCH $31.22
  • Average True Range (ATR)
  • AXSM 3.47
  • OPCH 0.61
  • MACD
  • AXSM 0.87
  • OPCH -0.09
  • Stochastic Oscillator
  • AXSM 64.95
  • OPCH 34.67

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About OPCH Option Care Health Inc.

Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.

Share on Social Networks: